These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6406877)

  • 1. [Lipid metabolism in hypertensive therapy. Measurements of electrolytes, lipids and lipoproteins in blood of normal and hypertensive individuals during repeated administration of Ebrantil].
    Mertz DP; Dittmann EC
    MMW Munch Med Wochenschr; 1983 May; 125(18):389-91. PubMed ID: 6406877
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of ebrantil, a new antihypertensive agent, on lipid metabolism and electrolyte balance].
    Mertz DP; Engelstätter R
    Fortschr Med; 1982 Nov; 100(42):1978-82. PubMed ID: 6961094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hypertensive crisis with ebrantil (urapidil)].
    Mleczko-Nycz Z; Kokot F
    Wiad Lek; 1984 Jun; 37(11):817-20. PubMed ID: 6390979
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fasting and postprandial lipids and lipoproteins during the chronic administration of antihypertensive drugs].
    Granados V; Ichazo S; Chávez J; Zamora J; Ochoa C; Cardoso G; Posadas C
    Arch Inst Cardiol Mex; 1994; 64(5):469-75. PubMed ID: 7840730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
    Uchida K; Azukizawa S; Kigoshi T; Nakano S; Kaneko M; Morimoto S; Matsui A
    Clin Ther; 1994; 16(3):466-70. PubMed ID: 7923313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cilnidipine on lipids, lipoproteins and fibrinolytic system in hypertensive patients.
    Ahaneku JE; Sakata K; Uranol T; Takada Y; Takada A
    Drugs Exp Clin Res; 2000; 26(4):119-23. PubMed ID: 11109511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
    Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
    Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urapidil in primary arterial hypertension].
    Román O; Sudy E; Gac JC; Valenzuela MA
    Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026
    [No Abstract]   [Full Text] [Related]  

  • 9. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
    Lacourcière Y; Arnott W
    J Hum Hypertens; 1994 Apr; 8(4):283-8. PubMed ID: 8021909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urapidil compared with diuretics in the treatment of mild-to-moderate essential hypertensive patients: effects on glucose metabolism, insulin sensitivity, and lipid profile.
    De Lima MD; Kohlmann NE; Neves FA; Zanella MT; Ribeiro AB; Kohlmann O
    Blood Press Suppl; 1994; 4():53-6. PubMed ID: 7804514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical assessment of ebrantil efficacy in arterial hypertension patients].
    Beregovaia NIa; Fishchenko AD; Vertkin AL; Belousov IuB; Martynov AI
    Klin Med (Mosk); 1995; 73(1):17-20. PubMed ID: 7791294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
    Oren S; Turkot S; Paran E; Flandra O; Slezak L; Hof B
    J Hum Hypertens; 1996 Feb; 10(2):123-7. PubMed ID: 8867567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of hypertensive crises. Profile of intravenous Ebrantil].
    Anaesthesist; 1994 Jun; 43(6 Suppl):1-4. PubMed ID: 9209532
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of effect of low doses of prazosin in hypertensive Nigerians.
    Falase AO; Salako LA; Aminu JM
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):603-11. PubMed ID: 819220
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of antihypertensive therapy on levels of lipids, lipoproteins and glucose in serum of patients with primary hypertension].
    Halawa B
    Pol Merkur Lekarski; 1997 Feb; 2(8):137-40. PubMed ID: 9538662
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ebrantil Byk in the treatment of hypertensive crises].
    Markiewicz M; Jach A; Mazur-Stazka E
    Wiad Lek; 1984 Jan; 37(1):1-4. PubMed ID: 6375141
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Shichiri M; Sunaga T; Mashiba H; Tanaka N; Nonaka K; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):366-70. PubMed ID: 7582390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficiency of food supplements rich of mineral substance in complex therapy of hypertensive disease in the Far North].
    Lekhanova EN; Kiriliuk LI; Romanova IuV
    Vopr Pitan; 2007; 76(6):65-8. PubMed ID: 18219945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil].
    Wacker J; Müller J; Grischke EM; Unkels R; Bastert G
    Zentralbl Gynakol; 1994; 116(5):271-3. PubMed ID: 8023622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.